Viewing Study NCT00504959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-01-13 @ 1:05 PM
Study NCT ID: NCT00504959
Status: COMPLETED
Last Update Posted: 2016-03-04
First Post: 2007-07-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Subfoveal Choroidal Neovascularization (CNV) View
None Secondary to Age-related Macular Degeneration (AMD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age-related macular degeneration (AMD), View
None choroidal neovascularization (CNV), View
None vascular endothelial growth factor (VEGF) View